Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.67
+0.41001.04%
Post-market: 35.74-3.9300-9.91%19:30 EDT
Volume:75.38K
Turnover:2.97M
Market Cap:259.84M
PE:- -
High:39.69
Open:39.05
Low:39.05
Close:39.26
52wk High:41.49
52wk Low:22.18
Shares:6.55M
Float Shares:6.55M
Volume Ratio:0.54
T/O Rate:1.15%
Dividend:0.28
Dividend Rate:0.71%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.
·
Aug 25

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Stock News
·
Aug 25

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
Aug 25

Savara announces presentations of Results from Phase 3 trial of Molgramostim

TIPRANKS
·
Aug 25

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Reuters
·
Aug 25

Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis

TradingKey
·
Aug 25

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Aug 24

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

TIPRANKS
·
Aug 24

U.S. Stocks on the MOVE-Jersey Mike's Sub, Moderna, PDD Holding

Reuters
·
Aug 24

BriaCell advances melanoma immunotherapy vaccine candidate Bria-MEL+

TIPRANKS
·
Aug 24

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Reuters
·
Aug 24

Barclays Adjusts Price Target on Moderna to $125 From $48

MT Newswires Live
·
Aug 24

Moderna price target raised to $125 from $48 at Barclays

TIPRANKS
·
Aug 24

BUZZ-US Stocks Weekly: Rate Rattle

Reuters
·
Aug 24

Ribomic Completes Site Network for Phase 3 Achondroplasia Trial in Japan

TIPRANKS
·
Aug 24

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.
·
Aug 24

24H | Tesla, Nvidia Jump 1% Each; Strategy Rises 2%; Alibaba Falls 2% as It Plans $10 Billion Hong Kong Share Placement; AAOI Tumbles 10%

US Overnight
·
Aug 24

Hype for Moderna's Cancer Vaccine is Running Ahead of the Math - Heard on the Street

Dow Jones
·
Aug 23

Moderna (MRNA) Posts First Late Stage mRNA Cancer Vaccine Win In Melanoma

Simply Wall St.
·
Aug 23

Moderna’s Shock Rally Redraws the Biotech Playbook

TIPRANKS
·
Aug 22